2nd Quarter - Report

FOLEY HOAG LLP for ASTRAZENECA PHARMACEUTICALS LP

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
$45,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report (this page) Jul 20, 2009 $45,000 Replaced
2nd Quarter - Amendment Nov 10, 2011 $45,000 Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

Patent Reform Bills- S. 515, H.R. 1260

LobbyistCovered position, as disclosed
DAVID MOHLER —
BARRETT THORNHILL —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Bills named: S. 515 (111th), H.R. 1260 (111th)

Health Issues HCR

FDA Globalization Act, H.R. 759 Follow-on biologics - H.R. 1427, H.R. 1548 Physician Payments Sunshine Act - S. 301 Comprehensive healthcare reform; S.__ Affordable Health Choices Act; America's Affordable Health Choices Act- H.R. 3200

LobbyistCovered position, as disclosed
KELLY CHILDRESS Congressman Rogers Staff; Congressman Shimkus, Staff
PAUL KIM —
DAVID MOHLER —
BARRETT THORNHILL —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3200 (111th), H.R. 1548 (111th), S. 301 (111th), H.R. 1427 (111th), H.R. 759 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.